After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
Brain scientists have developed DeepFocus, a novel technique to reach the deep brain without invasive surgery to treat mental ...
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...
Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results